HilleVax
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch HilleVax and buy or sell other stocks, ETFs, and their options commission-free!About HLVX
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214.
CEORobert M. Hershberg, MD, PhD
CEORobert M. Hershberg, MD, PhD
Employees14
Employees14
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2020
Founded2020
Employees14
Employees14
HLVX Key Statistics
Market cap104.76M
Market cap104.76M
Price-Earnings ratio-1.46
Price-Earnings ratio-1.46
Dividend yield—
Dividend yield—
Average volume333.91K
Average volume333.91K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.17
52 Week high$2.17
52 Week low$1.34
52 Week low$1.34
Stock Snapshot
With a market cap of 104.76M, HilleVax(HLVX) trades at $2.09. The stock has a price-to-earnings ratio of -1.46.
On 2025-12-07, HilleVax(HLVX) stock opened at —, reached a high of —, and a low of —.
The HilleVax(HLVX)'s current trading volume is 0, compared to an average daily volume of 333.91K.
In the last year, HilleVax(HLVX) shares hit a 52-week high of $2.17 and a 52-week low of $1.34.
In the last year, HilleVax(HLVX) shares hit a 52-week high of $2.17 and a 52-week low of $1.34.
People also own
Based on the portfolios of people who own HLVX. This list is generated using Robinhood data, and it’s not a recommendation.